Ann L. Oberg

Ann L. Oberg is a Professor of Biostatistics at Mayo Clinic College of Medicine and Science, holding full faculty privileges. She serves as Director of the Biostatistics Core for the Mayo Clinic Ovarian and Pancreatic Cancer SPORE programs, and Director of the Computational Genomics and Bioinformatics Unit for the Alliance for Clinical Trials in Oncology. Her work focuses on genomic data analysis, cancer risk modeling, and clinical trial design.

Education:

• PhD in Statistics, North Carolina State University
• MS in Biometry, University of Nebraska-Lincoln
• BS in Mathematics, University of Nebraska at Kearney

Research Interests: Dr. Oberg specializes in large-scale genomic data analysis (mRNA, protein mass spectrometry, DNA methylation) to identify disease markers and improve treatment strategies for ovarian and pancreatic cancers. She develops prognostic models, experimental designs for xenograft studies, and normalization methods for genomic datasets.

Grants & Projects:

• Multifactor Risk Score Development (NIH, 2023-2025)
• Pancreatic Cancer Detection Coordination (NIH, 2022-2025)
• Uterine Serous Carcinoma Therapeutics (NIH, 2009-2025)

Labs/Teams: Leads the Computational Genomics and Bioinformatics Unit and collaborates with the Mayo Clinic Comprehensive Cancer Center, Alliance for Clinical Trials in Oncology, and Pancreatic Cancer Early Detection Program.